Literature DB >> 16775537

"Why tell me now?" the public and healthcare providers weigh in on pandemic influenza messages.

Alan P Janssen1, Richard R Tardif, Sarah R Landry, Jo Ellen Warner.   

Abstract

As scientists closely watch avian influenza A (H5N1) or "bird flu" as a potential progenitor of an influenza pandemic, researchers from the Department of Health and Human Services, Centers for Disease Control and Prevention, and Oak Ridge Institute for Science and Education conducted with focus groups with the public and interviews with healthcare providers to test pandemic influenza messages. General public findings include variable awareness of pandemic influenza, subtle changes in terms (eg, flu or influenza), and challenged communication; and "vaccine priority group" opposition to the term priority group because it meant they could be left out. Healthcare providers reported Goggle and local infectious disease specialists as dominant sources of pandemic information. The results of the study provide specific guidance for those who will develop messages about pandemic influenza for the public and healthcare provider audiences.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16775537     DOI: 10.1097/00124784-200607000-00013

Source DB:  PubMed          Journal:  J Public Health Manag Pract        ISSN: 1078-4659


  13 in total

1.  Effective health risk communication about pandemic influenza for vulnerable populations.

Authors:  Elaine Vaughan; Timothy Tinker
Journal:  Am J Public Health       Date:  2009-10       Impact factor: 9.308

2.  Health-care provider preferences for time-sensitive communications from public health agencies.

Authors:  Debra Revere; Ian Painter; Mark Oberle; Janet G Baseman
Journal:  Public Health Rep       Date:  2014       Impact factor: 2.792

3.  Knowledge and attitudes of healthcare workers in Chinese intensive care units regarding 2009 H1N1 influenza pandemic.

Authors:  Xiaochun Ma; Zhenyang He; Yushan Wang; Li Jiang; Yuan Xu; Chuanyun Qian; Rongqing Sun; Erzhen Chen; Zhenjie Hu; Lihua Zhou; Fachun Zhou; Tiehe Qin; Xiangyuan Cao; Youzhong An; Renhua Sun; Xijing Zhang; Jiandong Lin; Yuhang Ai; Dawei Wu; Bin Du
Journal:  BMC Infect Dis       Date:  2011-01-25       Impact factor: 3.090

4.  Evaluation of a Web-based intervention to promote hand hygiene: exploratory randomized controlled trial.

Authors:  Lucy Yardley; Sascha Miller; Wolff Schlotz; Paul Little
Journal:  J Med Internet Res       Date:  2011-12-09       Impact factor: 5.428

5.  Community responses to communication campaigns for influenza A (H1N1): a focus group study.

Authors:  Lesley Gray; Carol MacDonald; Brenda Mackie; Douglas Paton; David Johnston; Michael G Baker
Journal:  BMC Public Health       Date:  2012-03-19       Impact factor: 3.295

6.  Public preferences for vaccination and antiviral medicines under different pandemic flu outbreak scenarios.

Authors:  Helena Rubinstein; Afrodita Marcu; Lucy Yardley; Susan Michie
Journal:  BMC Public Health       Date:  2015-02-27       Impact factor: 3.295

7.  What infection control measures will people carry out to reduce transmission of pandemic influenza? A focus group study.

Authors:  Leanne G Morrison; Lucy Yardley
Journal:  BMC Public Health       Date:  2009-07-23       Impact factor: 3.295

8.  Point-of-Care Testing as an Influenza Surveillance Tool: Methodology and Lessons Learned from Implementation.

Authors:  Lisa H Gren; Christina A Porucznik; Elizabeth A Joy; Joseph L Lyon; Catherine J Staes; Stephen C Alder
Journal:  Influenza Res Treat       Date:  2013-04-11

9.  Communicating risk to aboriginal peoples: first nations and Metis responses to H1N1 risk messages.

Authors:  S Michelle Driedger; Elizabeth Cooper; Cindy Jardine; Chris Furgal; Judith Bartlett
Journal:  PLoS One       Date:  2013-08-07       Impact factor: 3.240

10.  Assessing perceptions about hazardous substances (PATHS): the PATHS questionnaire.

Authors:  G James Rubin; Richard Amlôt; Lisa Page; Julia Pearce; Simon Wessely
Journal:  J Health Psychol       Date:  2012-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.